Cytoskeletal rescue of polarized atypical PKC in intestinal junctions under infla

炎症条件下肠连接处极化非典型 PKC 的细胞骨架拯救

基本信息

  • 批准号:
    8053457
  • 负责人:
  • 金额:
    $ 31.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Opening of tight junctions is involved in the pathogenesis of inflammatory bowel disease (IBD). Many studies have focused on the role of Tyr-kinases in the removal of tight junction components. However, no one has yet studied the role of atypical Protein Kinase C (aPKC), the evolutionarily conserved organizer of tight junctions, in inflammation. Our preliminary data shows a steep decrease of aPKC in intestinal epithelia exposed to pro- inflammatory signals. We have also shown that this effect is post-trancriptional and related to an Hsp-70- intermediate filament- dependent mechansim of rescue of aPKC. We hypothesize that post-translational mechanisms that recruit and maintain atypical PKC at the apical domain are impaired by inflammatory signals, resulting in increased tight junction permeability in the intestinal epithelium. We propose to: (1) Determine the molecular mechanisms by which Hsp70 chaperones rescue misfolded aPKC otherwise targeted for degradation. A combination of tissue culture of human intestinal cells, subcellular fractionation, and an in vitro reconstitution assay developed in our laboratory will be used to analyze the components of the aPKC rescue mechanisms. (2) Characterize molecular mechanisms that can antagonize loss of aPKC active conformation or degradation. Specific knock-down of Thr/Ser phosphatase catalytic subunits and expression of keratin intermediate filaments in human cells that normally lack them will be used to assess possible mechanisms to protect aPKC from losing its active conformation or to enhance the rescue mechanism. These observations will be validated in transgenic mice overexpressing keratin intermediate filaments. (3) Identify pro-inflammatory signals that downregulate aPKC and their targets in the degradation and rescue machinery that maintains aPKC physiologic levels. We will screen for pro-inflammatory cytokines that decrease aPKC levels, aside of TNF-, and analyze the step of the activation and degradation pathways of aPKC that are affected by pro-inflammatory signaling. Again, the results will be validated in an animal model PUBLIC HEALTH RELEVANCE: IBD is a chronic invalidating disease that affects around 3 million mericans. Increased permeability across the epithelial intestinal barrier is not the cause, but it is widely accepted as an important factor to perpetuate the inflammation. The studies in this project are intended to understand the molecular basis of a novel, as yet non studied mechanism to organize and maintain the "tightness" (tight junction competence) of the epithelial barrier.
描述(由申请人提供):紧密连接的开放与炎症性肠病(IBD)的发病机理有关。许多研究集中在Tyr-激酶在去除紧密连接组件中的作用。然而,尚无人研究非典型蛋白激酶C(APKC)在炎症中的进化保守的紧密连接的组织者。我们的初步数据显示,暴露于炎症信号的肠上皮中的APKC急剧下降。我们还表明,这种作用是终文后的,并且与HSP-70-依赖于APKC的HSP-70中间丝丝相关。我们假设炎症信号会损害募集和维持非典型PKC的翻译后机制,从而导致肠上皮上皮的紧密连接性渗透率增加。我们建议:(1)确定HSP70伴侣挽救异折叠APKC的分子机制,另有针对降解。在我们实验室开发的人类肠细胞的组织培养物,亚细胞分馏和体外重构测定法的结合将用于分析APKC救援机制的组成部分。 (2)表征可以拮抗APKC主动构象或降解的分子机制。 THR/SER磷酸酶催化亚基的特定敲低以及通常缺乏它们的角蛋白中间丝的表达,将用于评估保护APKC的可能机制,以防止APKC失去其活性构型或增强救援机制。这些观察结果将在过表达角蛋白中间细丝的转基因小鼠中得到验证。 (3)确定在维持APKC生理水平的降解和救援机制中下调APKC及其目标的促炎信号。我们将筛选出降低TNF-降低APKC水平的促炎性细胞因子,并分析受促炎性信号传导影响的APKC的激活和降解途径的步骤。同样,结果将在动物模型中得到验证 公共卫生相关性:IBD是一种慢性无效疾病,影响了约300万梅美洲人。在上皮肠壁上的渗透性提高并不是原因,而是被广泛认为是使炎症永存的重要因素。该项目中的研究旨在理解新颖的分子基础,但尚未研究的机制,以组织和维持上皮屏障的“紧密连接能力”(紧密连接能力)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pedro Salas其他文献

Pedro Salas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pedro Salas', 18)}}的其他基金

Apico-basal Polarity Signaling Controls Expression of Epithelial Cyrokines Through NF-kB
Apico-基底极性信号通过 NF-kB 控制上皮细胞因子的表达
  • 批准号:
    9897416
  • 财政年份:
    2018
  • 资助金额:
    $ 31.43万
  • 项目类别:
Acquisition of a Transmission Electron Microscope to Reactivate Facility
购置透射电子显微镜以重新启动设施
  • 批准号:
    8247527
  • 财政年份:
    2012
  • 资助金额:
    $ 31.43万
  • 项目类别:
Cytoskeletal rescue of polarized atypical PKC in intestinal junctions under infla
炎症条件下肠连接处极化非典型 PKC 的细胞骨架拯救
  • 批准号:
    8209294
  • 财政年份:
    2010
  • 资助金额:
    $ 31.43万
  • 项目类别:
Cytoskeletal rescue of polarized atypical PKC in intestinal junctions under infla
炎症条件下肠连接处极化非典型 PKC 的细胞骨架拯救
  • 批准号:
    8400421
  • 财政年份:
    2010
  • 资助金额:
    $ 31.43万
  • 项目类别:
Cytoskeletal rescue of polarized atypical PKC in intestinal junctions under infla
炎症条件下肠连接处极化非典型 PKC 的细胞骨架拯救
  • 批准号:
    7837371
  • 财政年份:
    2010
  • 资助金额:
    $ 31.43万
  • 项目类别:
Apical Ezrin Assembly the Cytoskeleton and Diarrheal Disorders
顶端埃兹蛋白组装细胞骨架和腹泻疾病
  • 批准号:
    8010945
  • 财政年份:
    2007
  • 资助金额:
    $ 31.43万
  • 项目类别:
Apical Polarity Complex Signaling in Inflammation in Intestinal Epithelia
肠上皮炎症中的顶端极性复合信号传导
  • 批准号:
    8371947
  • 财政年份:
    2007
  • 资助金额:
    $ 31.43万
  • 项目类别:
Apical Polarity Complex Signaling in Inflammation in Intestinal Epithelia
肠上皮炎症中的顶端极性复合信号传导
  • 批准号:
    8495319
  • 财政年份:
    2007
  • 资助金额:
    $ 31.43万
  • 项目类别:
Apical Polarity Complex Signaling in Inflammation in Intestinal Epithelia
肠上皮炎症中的顶端极性复合信号传导
  • 批准号:
    8695333
  • 财政年份:
    2007
  • 资助金额:
    $ 31.43万
  • 项目类别:
Apical Ezrin Assembly the Cytoskeleton and Diarrheal Disorders
顶端埃兹蛋白组装细胞骨架和腹泻疾病
  • 批准号:
    7177179
  • 财政年份:
    2007
  • 资助金额:
    $ 31.43万
  • 项目类别:

相似海外基金

Arlene George F32
阿琳·乔治 F32
  • 批准号:
    10722238
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
Investigation of UBQLN2 in neuronal dysfunction and ALS-FTD
UBQLN2 在神经元功能障碍和 ALS-FTD 中的研究
  • 批准号:
    10638277
  • 财政年份:
    2023
  • 资助金额:
    $ 31.43万
  • 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
  • 批准号:
    10678062
  • 财政年份:
    2023
  • 资助金额:
    $ 31.43万
  • 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 31.43万
  • 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
  • 批准号:
    10797938
  • 财政年份:
    2023
  • 资助金额:
    $ 31.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了